Thrombocyte aggregation inhibiting composition and methods

Details Thrombocyte aggregation inhibiting composition and methods Thrombocyte aggregation inhibiting composition and methods

1979-08-07

1981-07-21

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

424260, A61K 3147, A61K 31485

Patent

active

042799147

ABSTRACT:
Platelet aggregation inhibiting compositions containing as active agent at least one compound selected from the group consisting of tetrahydroxyaporphine, glaucine containing 50 to 100% l-glaucine, and the physiologically acceptable salts and N-alkyl ammonium salts thereof are disclosed, as is a method for inhibiting platelet aggregation by administration of effective dosages of such compounds admixed with suitable carriers.

REFERENCES:
patent: 2951013 (1960-08-01), Dengel
patent: 3795675 (1974-03-01), Laguzzi
patent: 3810987 (1974-05-01), Saari
patent: 3823234 (1974-07-01), Mauvernay
patent: 3910927 (1975-10-01), Kreighbaum et al.
patent: 4018927 (1977-04-01), Voorhees
patent: 4080456 (1978-03-01), Seidelmann et al.
The Pharmacological Basis of Therapeutics-pp. 279-280 (1966).
Chem. Abst. 58 4941(h), 1963-Vernadakis et al.
Chem. Abst. 61 9928(g), 1964-Donev.

Affiliated with

Also associated with

Rating

Thrombocyte aggregation inhibiting composition and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thrombocyte aggregation inhibiting composition and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombocyte aggregation inhibiting composition and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2433087